Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC(-) cells and CD4(+)CD8(-) thymocytes
B. Seddon et D. Mason, Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC(-) cells and CD4(+)CD8(-) thymocytes, J EXP MED, 189(2), 1999, pp. 279-288
Previous studies have shown that induction of autoimmune diabetes by adult
thymectomy and split dose irradiation of PVG.RT1(u) rats can be prevented b
y their reconstitution with peripheral CD4(+)CD45RC(-)TCR-alpha/beta(+)RT6(
+) cells and CD4(+)CD8(-) thymocytes from normal syngeneic donors. These da
ta provide evidence for the role of regulatory T cells in the prevent-ion o
f a tissue-specific autoimmune disease but the mode of action of these cell
s has not been reported previously. In this study, autoimmune thyroiditis w
as induced in PVG.RT1(c) rats using a similar protocol of thymectomy and ir
radiation. Although a cell-mediated mechanism has been implicated in the pa
thogenesis of diabetes in PVG.RT1(u) rats, development of thyroiditis is in
dependent of CD8(+) T cells and is characterized by high titers of immunogl
obulin (Ig)G1 antithyroglobulin antibodies, indicating a major humoral comp
onent in the pathogenesis of disease. As with autoimmune diabetes in PVG.RT
1(u) rats, development of thyroiditis was prevented by the transfer of CD4(
+)CD45RC(-) and CD4(+)CD8(-) thymocytes from normal donors but not by CD4()CD45RC(+) peripheral T cells. We now show that transforming growth factor
(TGF)-beta and interleukin (IL)-4 both play essential roles in the mechanis
m of this protection since administration of monoclonal antibodies that blo
ck the biological activity of either of these cytokines abrogates the prote
ctive effect of the donor cells in the recipient rats. The prevention of bo
th diabetes and thyroiditis by CD4(+)CD45RC(-) peripheral cells and CD4(+)C
D8(-)thymocytes therefore does not support the view that the mechanism of r
egulation involves a switch from a T helper cell type 1 (Th1) to a Th2-like
response, but rather relies upon a specific suppression of the autoimmune
responses involving TGF-beta and IL-4. The observation that the same two cy
tokines were implicated in the protective mechanism, whether thymocytes or
peripheral cells were used to prevent autoimmunity, strongly suggests that
the regulatory cells from both sources act in the same way and that the thy
mocytes are programmed in the periphery for their protective role. The impl
ications of this result with respect to immunological homeostasis are discu
ssed.